当前位置:
首页>产品中心>单抗/多抗>Certolizumab ELISA Kit|Certolizumab ELISA试剂盒(靶标:)
Certolizumab ELISA Kit|Certolizumab ELISA试剂盒(靶标:)
- 货号:RB9TDF879028
- 价格:面议
- 点击:442
产品介绍
产品参数
| 应用 | ELISA |
|---|
| 检测方法 | Colorimetric |
|---|
| 灵敏度 | 329.66 ng/mL |
|---|
| 检测范围 | 468.75 - 30, 000 ng/mL |
|---|
| 回收率 | 80-120% |
|---|
| 样本类型 | Plasma, Serum |
|---|
| 检测类型 | Quantitative |
|---|
| 稳定性和储存 | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20 ℃, the rest reagents should be store at 4℃. |
|---|
| 运输条件 | 2-8 ℃ |
|---|
| 登录号 | P01375 |
|---|
| 背景信息 | Certolizumab pegol is a recombinant, humanized F(ab)’ fragment of an antibody conjugated to polyethylene glycol to enhance its plasma half-life. It does not contain an FC region and therefore does not cause antibody-dependent cell-mediated or complement-dependent cytotoxicity as described for infliximab, etanercept, and adalimumab. Another difference is that certolizumab pegol preferentially penetrates inflamed tissue compared to noninflamed tissue, and does so to a greater extent than adalimumab or infliximab. It is directed against soluble and membrane-associated human TNF-α and was approved for the treatment of Crohn’s disease that does not respond to conventional therapy in 2008 and for RA in 2009. |
|---|
| 别名 | CDP870, PHA-738144, Certolizumab pegol, 428863-50-7 |
|---|
| 备注 | For Research Use Only. |
|---|
【仅供科学研究使用】
相关产品: